Suven Pharmaceuticals Q4 Results
- BSE: 543064
- NSE: SUVENPHAR
- ISIN: INE03QK01018
- Sector: Biotechnology & Drugs
BSE
1,275.05
-19.30 (-1.49%)
-19.30 (-1.49%)Volume18.75 K
Updated: Mon 25 Nov, 2024 | 15:29:44
NSE
1,293.9-1.25 (-0.10%)
-1.25 (-0.10%)Volume4.21 L
Updated: Mon 25 Nov, 2024 | 15:31:16
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Suven Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 22 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 252.93 | 353.77 | -% | 369.36 | -% |
| Selling/ General/ Admin Expenses Total | 39.39 | 29.68 | -% | 25.60 | -% |
| Depreciation/ Amortization | 17.25 | 12.24 | -% | 11.96 | -% |
| Other Operating Expenses Total | 19.94 | 18.13 | -% | 15.77 | -% |
| Total Operating Expense | 196.83 | 219.32 | -% | 212.24 | -% |
| Operating Income | 56.10 | 134.46 | -% | 157.12 | -% |
| Net Income Before Taxes | 70.85 | 146.08 | -% | 166.21 | -% |
| Net Income | 53.37 | 107.72 | -% | 123.97 | -% |
| Diluted Normalized EPS | 2.10 | 4.23 | -% | 4.87 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST